✦ LIBER ✦

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Scribed by Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKearn; Robert W. Ross; Philip W. Kantoff; Mary-Ellen Taplin; William K. Oh

Book ID: 109053698
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 86 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.07331.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First- and second-line chemotherapy with

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer : Does sequence matter?

✍ Jorg Michels; Trina Montemurro; Nevin Murray; Christian Kollmannsberger; Kim Ngu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

A retrospective evaluation of second-lin

A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma : Second-line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy

✍ Jonathan E. Rosenberg; Matthew D. Galsky; Nicholas C. Rohs; Vivian K. Weinberg; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Editorial Comment to docetaxel-based com

Editorial Comment to docetaxel-based combination chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival

✍ Takeshi Yuasa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB